1. Home
  2. DT vs ALGN Comparison

DT vs ALGN Comparison

Compare DT & ALGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dynatrace Inc.

DT

Dynatrace Inc.

HOLD

Current Price

$50.98

Market Cap

12.7B

Sector

Technology

ML Signal

HOLD

Logo Align Technology Inc.

ALGN

Align Technology Inc.

HOLD

Current Price

$159.94

Market Cap

12.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DT
ALGN
Founded
2005
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Industrial Specialties
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.7B
12.7B
IPO Year
2019
2000

Fundamental Metrics

Financial Performance
Metric
DT
ALGN
Price
$50.98
$159.94
Analyst Decision
Strong Buy
Buy
Analyst Count
26
12
Target Price
$51.77
$199.82
AVG Volume (30 Days)
6.4M
868.3K
Earning Date
05-13-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
0.53
EPS
0.12
3.09
Revenue
$2,018,387,000.00
$387,126,000.00
Revenue This Year
$21.74
$5.78
Revenue Next Year
$14.85
$4.62
P/E Ratio
$417.25
$51.65
Revenue Growth
18.82
23.95
52 Week Low
$31.64
$122.00
52 Week High
$53.29
$200.44

Technical Indicators

Market Signals
Indicator
DT
ALGN
Relative Strength Index (RSI) 62.03 38.69
Support Level $42.56 $153.68
Resistance Level $52.64 $184.63
Average True Range (ATR) 1.76 5.77
MACD -0.06 -1.40
Stochastic Oscillator 67.69 10.69

Price Performance

Historical Comparison
DT
ALGN

About DT Dynatrace Inc.

Dynatrace is a software-as-a-service company that enables customers to monitor and analyze their information technology infrastructure, from servers to applications and Python scripts. Dynatrace's unified platform can ingest and analyze large amounts of machine-generated data in real time, allowing clients to optimize their business for service-level objectives and ensure uptime.

About ALGN Align Technology Inc.

Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.

Share on Social Networks: